You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仙琚製藥(002332.SZ):終止後續投資美國Occulo公司
格隆匯 12-26 18:04

格隆匯12月26日丨仙琚製藥(002332.SZ)發佈公告,公司此前董事會會議審議通過了《關於投資參股美國 Occulo公司的議案》。同意公司以自有現金,以分階段出資方式,投資1,200萬美元購買美國Occulo Holdings, LLC公司(以下簡稱“Occulo公司”)A類優先股5400萬股,若投資完成後公司將持有Occulo公司36.5854%的股權。根據公司聚焦甾體激素和四大治療領域的戰略定位,經與Occulo公司及其他投資方充分溝通及友好協商,公司決定終止後續投資,已投資的268萬美元轉換成A類普通股1206萬股,終止投資後公司將持有Occulo公司11.734%的股權。

公告表示,基於近兩年醫藥行業變化和公司的戰略定位,經與 Occulo 公司及其他投資方充分溝通及友好協商,公司本次終止後續投資,符合公司的發展戰略,有利於公司更加聚焦主業,不會對公司生產經營和財務狀況產生不利影響,不存在損害上市公司及全體股東利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account